- Sort by:
- Browse by:
Welcome
Jose Baselga, MD, PhD
AACR Immediate Past President
Physician-in-Chief
Memorial Sloan Kettering Cancer Center
New York, NY
Physician-in-Chief
Memorial Sloan Kettering Cancer Center
New York, NY
Video Tribute to Vice President Biden
Introduction of Jill Biden
Introduction of Jill Biden
Sophia Lunt
Assistant Professor, Biochemistry and Molecular Biology
Michigan State University
East Lansing, Michigan
Michigan State University
East Lansing, Michigan
Introduction of Vice President Biden
Jill Biden
Second Lady of the United States
Vice President Biden's Address to AACR Annual Meeting 2016
Joe Biden
Vice President of the United States
- Free
- podium video
- audio only
- Audio only
Basic mechanisms and new therapeutic combinations
Scott A. Armstrong
Memorial Sloan Kettering Cancer Center, New York, NY, United States
- Free
- Unknown permission
for presentation
Precision medicine breakthroughs
Jose Baselga
Memorial Sloan Kettering Cancer Center, New York, NY, United States
- Free
- podium video
- slides video
- audio + slides
- All slides included
Prevention and early detection of cancer: Challenges and opportunities
Elaine R. Mardis
Washington University School Of Medicine, Saint Louis, MO, United States
- Free
- podium video
- slides video
- audio + slides
- All slides included
Wrap-up and vision for the future
Nancy E. Davidson
University of Pittsburgh Cancer Institute, Pittsburgh, PA, United States
- Free
- slides video
- audio + slides
- All slides included
Invited Speaker
Robert D. Schreiber
Washington University School of Medicine, St. Louis, MO, United States
- Free
- slides video
- audio + slides
- All slides included
Invited speaker
Elsa R. Flores
UT MD Anderson Cancer Center, Houston, TX, United States
- Free
- audio + slides
- Some slides withheld
Invited speaker
Tyler Jacks
David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA, United States
- Free
- slides video
- audio + slides
- All slides included
Invited speaker
Jason S. Lewis
Memorial Sloan Kettering Cancer Center, New York, NY, United States
- Free
- audio + slides
- Some slides withheld
Invited speaker
Ezra E. W. Cohen
UCSD Moores Cancer Center, San Diego, CA, United States
- Free
- audio only
- Audio only
Invited speaker
Cyrus M. Ghajar
Fred Hutchinson Cancer Research Ctr., Irvine, CA, United States
- Permission not
granted for presentation
Invited Speaker
Michal Lotem
Hadassah Univ. Medical Ctr.-Sha, Jerusalem, Israel
- Free
- slides video
- audio + slides
- All slides included
Invited speaker
Trey Ideker
University of California - San Diego, La Jolla, CA, United States
- Free
- slides video
- audio + slides
- All slides included
Liquid biopsies and the early diagnosis of cancer
Luis A. Diaz
Johns Hopkins Kimmel Comp. Cancer Center, Baltimore, MD, United States
- Free
- audio + slides
- Some slides withheld
Heterogeneity, drug resistance, and clonal evolution in colorectal cancers
Alberto Bardelli
University of Turin, Dept. Oncology - Candiolo Cancer Institute IRCCS, Candiolo, Italy
- Permission not
granted for presentation
Developing circulating tumor cell derived explant models (CDX)
Caroline Dive
CRUK Manchester Institute, Manchester, United Kingdom
- Free
- slides video
- audio + slides
- All slides included
Clonal hematopoiesis of indeterminate potential
Benjamin Ebert
Brigham & Women's Hospital, Boston, MA, United States
- Free
- audio + slides
- Some slides withheld
Translational Relevance of Molecular Subtypes of Gastric Cancer and Associated Model Systems
Amit Agarwal
Eli Lilly and Company, Indianapolis, IN, United States
- Free
- slides video
- audio + slides
- All slides included
Clinical sequencing program in metastatic gastric cancer patients at Samsung Medical Center: Translation from sequence-preclinical-clinical trials
Jeeyun Lee
Samsung Medical Center, Sungkyunkwan University, Korea, Republic of
- Free
- audio + slides
- Some slides withheld
New horizons in gastric cancer treatment
Atsushi Ohtsu
National Cancer Center Hospital E, Kashiwa, Japan
- Free
- slides video
- audio + slides
- All slides included
Targeting oncogeneic and host pathways to promote immunotherapy responsiveness
Thomas Frank Gajewski
University of Chicago, Chicago, IL, United States
- Free
- slides video
- audio + slides
- All slides included
Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity
Thomas W. Dubensky
Aduro Biotech, Inc., Berkeley, CA, United States
- Permission not
granted for presentation
IDO1 inhibition as a modifier of the immune composition of the tumor microenvironment and a component of combination immunotherapy for cancer
Peggy A. Scherle
Incyte Corporation, Wilmington, DE, United States
- Free
- audio + slides
- Some slides withheld
Remodeling the tumor microenvironment through oncogene inactivation
Dean W. Felsher
Stanford University School of Medicine, Stanford, CA, United States
- Permission not
granted for presentation
Targeting cancer through cell-death associated inflammation
Stephen Tait
University of Glasgow, Glasgow, United Kingdom